Phase 3 – Testing and Integration of NGS Workflows

Duration: 16th April 2024 to 15th May 2025  

During Phase 3 the Buyers will test the developed prototypes in a real world medical environment and integrate them into a full NGS workflow.

Information for Contractors (Phase 3)

Phase 3 Awards 

Budget of awarded contracts: 2.220.774,20 EUR

Proposals received: 10

Number of Contracts awarded: 8

Lot 1: Pre-Sequencing: 2

Lot 2: Sequencing:  Due to the insufficient number of tenders received, no contract was awarded for Lot 2 in Phase 1.

Lot 3: Bioinformatics Analysis: 3

Lot 4: Integrated Reporting: 3

Selected Contractors:

Lot 1: Pre-Sequencing 

Lead: QIAGEN GmbH
 
TwistPlatomicsMGI – Project abstract
Lead: Twist Bioscience Corporation
 
 

Lot 3: Bioinformatics Analysis

Congenica L3 – Project abstract
Lead: Congenica Limited BIC Wellcome Genome Campus
Consortium members: Single tenderer
 
Cancer Analysis GPAP – Project abstract
Lead: FUNDACIO CENTRE DE REGULACIO GENOMICA
Consortium members: Single tenderer
PlatoDKFZCharité – Project abstract 
Lead: Platomics GmbH
Consortium members: Deutsches Krebforschungszentrum, Charité Universitätsmedizin Berlin
 

Lot 4: Integrated Reporting

Cancer Reporting GPAP – Project abstract
Lead: FUNDACIO CENTRE DE REGULACIO GENOMICA
Consortium members: Single tenderer
 
Congenica L4 – Project abstract
Lead: Congenica Limited BIC Wellcome Genome Campus
Consortium members: Single tenderer
 
EU Onco Platform L4 – Project abstract
Lead: BC Platforms AG
Consortium members: Euformatics Oy, Oncompass Medicine Hangary Kft.